Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of hepatitis B and C clearance on atazanavir exposure.

× No keyword cloud information.

11 in total

1. Acute renal failure and liver toxicity in an HIV/hepatitis C coinfected patient receiving telaprevir and boosted atazanavir.

Authors: Eva Van den Eynde; Elena Ferrer; Daniel Podzamczer
Journal: AIDS Date: 2014-06-19 Impact factor: 4.177

2. Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis.

Authors: G M Kirby; G Batist; L Alpert; E Lamoureux; R G Cameron; M A Alaoui-Jamali
Journal: Toxicol Pathol Date: 1996 Jul-Aug Impact factor: 1.902

3. A novel hepatitis B virus X-interactive protein: cytochrome C oxidase III.

Authors: Xiao Zhong Wang; Dan Li; Qi Min Tao; Na Lin; Zhi Xin Chen
Journal: J Gastroenterol Hepatol Date: 2006-04 Impact factor: 4.029

4. Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders.

Authors: Laura Milazzo; Dario Cattaneo; Elisa Calvi; Cristina Gervasoni; Cristina Mazzali; Paola Ronzi; Anna Maria Peri; Anna Lisa Ridolfo; Antonio D'Avolio; Spinello Antinori
Journal: Int J Antimicrob Agents Date: 2015-02-21 Impact factor: 5.283

5. High levels of atazanavir and darunavir in urine and crystalluria in asymptomatic patients.

Authors: Victoire de Lastours; Erika Ferrari Rafael De Silva; Michel Daudon; Raphaël Porcher; Benedicte Loze; Hélène Sauvageon; Jean-Michel Molina
Journal: J Antimicrob Chemother Date: 2013-04-18 Impact factor: 5.790

Review 6. Clinical pharmacology, efficacy and safety of atazanavir: a review.

Authors: Danièle Bentué-Ferrer; Cédric Arvieux; Olivier Tribut; Annick Ruffault; Eric Bellissant
Journal: Expert Opin Drug Metab Toxicol Date: 2009-11 Impact factor: 4.481

7. Effects of interferon-alpha on cytochrome P-450 isoforms 1A2 and 3A activities in patients with chronic hepatitis C.

Authors: G P Pageaux; Y le Bricquir; F Berthou; N Bressot; M C Picot; F Blanc; H Michel; D Larrey
Journal: Eur J Gastroenterol Hepatol Date: 1998-06 Impact factor: 2.566

8. Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis.

Authors: Yongdong Niu; Zheng Wu; Qiujin Shen; Jin Song; Qin Luo; Haiyan You; Ganggang Shi; Wenxin Qin
Journal: Dig Liver Dis Date: 2013-07-26 Impact factor: 4.088

9. Influence of chronic hepatitis C infection on cytochrome P450 3A4 activity using midazolam as an in vivo probe substrate.

Authors: P N Morcos; S A Moreira; B J Brennan; S Blotner; N S Shulman; P F Smith
Journal: Eur J Clin Pharmacol Date: 2013-06-14 Impact factor: 2.953

Review 10. Telaprevir: clinical pharmacokinetics, pharmacodynamics, and drug-drug interactions.

Authors: Tony K L Kiang; Kyle J Wilby; Mary H H Ensom
Journal: Clin Pharmacokinet Date: 2013-07 Impact factor: 5.577